Clinical trial
A Study Looking Into the Effect of NNC 55-0414 in Subjects With Type 2 Diabetes
NCT00400283 · Novo Nordisk A/S, Industry · Completed
Key facts
| NCT number | NCT00400283 |
|---|---|
| Title | A Study Looking Into the Effect of NNC 55-0414 in Subjects With Type 2 Diabetes |
| Official title | A Randomised, Double-blind, Placebo-controlled, Multiple Oral Dose, Dose Escalation Trial, Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC 55-0414 in Patients With Type 2 Diabetes |
| Lead sponsor | Novo Nordisk A/S, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Diabetes, Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | NNC 55-0414 |
| Enrollment | 23 |
| Start date | Jan 19, 2001 |
| Primary completion | May 3, 2001 |
| Completion | May 3, 2001 |
| First posted | Nov 16, 2006 |
| Last update posted | Feb 24, 2017 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: